Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy

The aim of the current study is to evaluate the prognostic value of anemia, an easily estimable parameter in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) immunochemotherapy. A total of 157 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Junshik, Woo, Hyun Seon, Kim, Hyunchul, Ahn, Hee Kyung, Sym, Sun Jin, Park, Jinny, Ahn, Jeong Yeal, Cho, Eun Kyung, Shin, Dong Bok, Lee, Jae Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317957/
https://www.ncbi.nlm.nih.gov/pubmed/25263825
http://dx.doi.org/10.1111/cas.12544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317957/
https://www.ncbi.nlm.nih.gov/pubmed/25263825
http://dx.doi.org/10.1111/cas.12544

Ejemplares similares